Hematopoietic and Lymphatic System NeoplasmGenetics
What this study is
This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.
What's being tested
- Non-Interventional Study
Intervention · OTHER
Non-interventional study
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
- Enrolling
- 30 people
- Starts
- 2025-01-13
- Est. completion
- 2026-12-15
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Any patient >= 18 years of age
- Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies
You can't join if
- Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic in Florida
Jacksonville, Florida, United States
- Clinical Trials Referral Office · Contact855-776-0015mayocliniccancerstudies@mayo.edu
- Nadine Norton, PhD · Principal investigator
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID MC240101
Principal investigator
Nadine Norton, PhD
Mayo Clinic
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.